Fast Fix Mental Health

The idea

I think a generation raised on instant everything will have zero patience for six-week antidepressants or months of therapy, so demand shifts toward treatments that work in hours or days. The basket pairs big pharma with established psychiatric franchises, like ketamine-based medicines, for ballast at 35%, with specialist brain-drug companies at 28%, rapid-acting depression treatments at 17%, and a smaller slice of psychedelics and ketamine names at 10%. I keep 10% in cash to add on volatile days and I am not betting the whole idea on any single name.